Acurx Pharmaceuticals's top three insider shareholders as of September 09, 2026 are Robert J Deluccia (Director, 1.01Mn shares), Carl Sailer (Director, 137.18K shares), Joseph C Scodari (Director, 27.71K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Robert J Deluccia | Director, TenPercentOwner | 1,010,196 | 0 | 1,010,196 | 82.9% | 08 Jan, 2025 |
| 2 | Carl Sailer | Director | 137,183 | 0 | 137,183 | 11.3% | 08 Jan, 2025 |
| 3 | Joseph C Scodari | Director | 27,708 | 0 | 27,708 | 2.3% | 08 Jan, 2025 |
| 4 | James J. Donohue | Director | 22,352 | 0 | 22,352 | 1.8% | 08 Jan, 2025 |
| 5 | Jack H Dean | Director | 21,776 | 0 | 21,776 | 1.8% | 08 Jan, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 20 Apr, 2026 | Jack H Dean | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 20 Apr, 2026 | James J. Donohue | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 20 Apr, 2026 | Carl Sailer | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 20 Apr, 2026 | James J. Donohue | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 20 Apr, 2026 | David P Luci | President And Ceo | Acquired A | 37,100 | $0.00 | $0 | 37,100 | Direct |
| 20 Apr, 2026 | James J. Donohue | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 20 Apr, 2026 | Robert J Deluccia | Director | Acquired A | 37,100 | $0.00 | $0 | 37,100 | Direct |
| 20 Apr, 2026 | Robert G. Shawah | Chief Financial Officer | Acquired A | 25,900 | $0.00 | $0 | 25,900 | Direct |
| 20 Apr, 2026 | Joseph C Scodari | Director | Acquired A | 2,150 | $0.00 | $0 | 2,150 | Direct |
| 05 Feb, 2025 | Robert J Deluccia | Director, TenPercentOwner | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 05 Feb, 2025 | Robert G. Shawah | Chief Financial Officer | Acquired A | 145,500 | $0.00 | $0 | 145,500 | Direct |
| 06 Jan, 2025 | James J. Donohue | Director | Acquired P | 9,852 | $1.02 | $10.00K | 22,352 | Direct |
| 06 Jan, 2025 | Jack H Dean | Director | Acquired P | 9,852 | $1.02 | $10.00K | 21,776 | Direct |
| 06 Jan, 2025 | Robert J Deluccia | Director, TenPercentOwner | Acquired P | 49,261 | $1.02 | $50.00K | 1,010,196 | Direct |
| 06 Jan, 2025 | James J. Donohue | Director | Acquired P | 9,852 | $1.02 | $10.00K | 22,352 | Direct |
| 06 Jan, 2025 | James J. Donohue | Director | Acquired P | 9,852 | $1.02 | $10.00K | 22,352 | Direct |
| 06 Jan, 2025 | James J. Donohue | Director | Acquired P | 9,852 | $1.02 | $10.00K | 22,352 | Direct |
| 06 Jan, 2025 | Joseph C Scodari | Director | Acquired P | 24,631 | $1.02 | $25.00K | 27,708 | Direct |
| 06 Jan, 2025 | Carl Sailer | Director | Acquired P | 24,631 | $1.02 | $25.00K | 137,183 | Direct |
| 06 Jan, 2025 | James J. Donohue | Director | Acquired P | 9,852 | $0.00 | $0 | 9,852 | Direct |